Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first

Eray Eroglu1, Ismail Kocyigit, Ozturk Ates

  • 1Department of Internal Medicine, Erciyes University Medical School, Kayseri, Turkey. drerayeroglu@hotmail.com

Insights

Familial Mediterranean Fever (FMF) patients can develop non-amyloid kidney disease like glomerulonephritis, even with the E148Q mutation. Colchicine may effectively treat this condition in FMF patients.

Area of Science:

  • Nephrology
  • Genetics
  • Rheumatology

Background:

  • Familial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disease.
  • Renal involvement in FMF commonly presents as amyloidosis.
  • Non-amyloid renal lesions, including glomerulonephritis, are less common but documented.